Roche Molecular Systems Enterprise Account Executive Salaries in San Francisco
The average Roche Molecular Systems Enterprise Account Executive in San Francisco earns an estimated $117,261 annually, which includes an estimated base salary of $90,218 with a $27,043 bonus. Roche Molecular Systems' Enterprise Account Executive compensation is $3,787 more than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at Roche Molecular Systems in San Francisco can range from $52,000 - $205,000.
In San Francisco, The Business Development Department at Roche Molecular Systems earns $757 more on average than the Design Department.
Last updated a year ago.
- $90,218
- avg. base
- $27,043
- avg. bonus
Enterprise Account Executive Salaries at Roche Molecular Systems
In San Francisco, Enterprise Account Executives earn $6,543 more than Account Executives, and $17,360 less than Account Managers.
Compensation at Roche Molecular Systems by Department
In San Francisco, The Business Development Department averages $757 more than the Design Department, and $2,814 less than the HR Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to Roche Molecular Systems reported making $115,417, while the average male Enterprise Account Executive at similar sized companies reported making $130,365.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average African American/Black Enterprise Account Executive at companies similar size to Roche Molecular Systems reported making $130,663, while the average Hispanic or Latino Enterprise Account Executive at similar sized companies reported making $107,000.
How Enterprise Account Executives at Roche Molecular Systems Rate Their Compensation
The majority of Enterprise Account Executives at Roche Molecular Systems believe they're compensated fairly. 100% of Enterprise Account Executives at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
